- Winter weather brings higher health risks.
- Snow and ice cause slips and falls.
- Driveways and ground can become frozen.
- Respiratory viruses rise in winter.
- Influenza, COVID-19 and RSV increase.
- Arjun Venkatesh is a professor and chair at Yale School of Medicine.
- He is chief of emergency medicine at Yale New Haven Hospital.
- Four years ago he gave a news interview.
- Two days after the interview he slipped at home.
- It was late at night after a hospital shift.
Difficult words
- respiratory — About breathing and the lungs
- influenza — A virus that makes people very sick
- slipped — To lose balance and fall
- professor — A teacher and leader at a university
- emergency — A sudden medical or dangerous problem
- frozen — Turned to ice because of very cold
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever slipped on ice?
- Do you get sick more in winter?
- Do you walk carefully when the ground is frozen?
Related articles
Calorie restriction improves muscle insulin response in old rats
In 24-month-old rats, eating 35% less for eight weeks changed many muscle proteins and improved insulin-stimulated glucose uptake. Males and females showed different molecular responses, and two proteins may be targets for diabetes treatment.
Experts call for integrated One Health surveillance linking communities
Experts urge governments to build integrated surveillance systems that link community-level data across human, animal, plant and environmental sectors. A virtual roundtable highlighted research priorities and named integrated surveillance the most urgent need.
Gut has a backup system for IgA antibodies
Researchers found two different routes that make IgA antibodies in the gut. Early IgA often comes from non‑germinal center cells but later from germinal centers; both types showed similar specificity and mutations, which may help vaccine design.
New modular CAR-T system controls where and when cells attack
Researchers at the University of Chicago created GA1CAR, a modular CAR-T system that uses short-lived Fab fragments to guide and pause tumor targeting. In animal tests the same cells were redirected to different tumors and remained functional.